A study investigating factors that influence the initiation of brief behavioral treatment (BT) and medication-based treatment for opioid use disorder (MOUD) found that patients who received “collaborative care” were over six times more likely to begin BT compared to control groups. Patients who received MOUD were more than five times more likely to initiate BT, with a majority undergoing BT prior to starting MOUD. Although the study did not analyze the timing of BT and MOUD, collaborative care appeared to facilitate BT initiation through a warm handoff and follow-up by a care coordinator, potentially enabling subsequent MOUD initiation after a comprehensive assessment and discussion of treatment options. The study specifically focused on buprenorphine or naltrexone as the MOUD options.
Read the full study here